How Can We Distinguish Ventilator-Associated Tracheobronchitis from Pneumonia?

Area of Science:

• Critical care medicine
• Infectious disease
• Respiratory medicine

Background:

• Ventilator-associated tracheobronchitis (VAT) is a potential precursor to ventilator-associated pneumonia (VAP).
• Current preventative measures have largely failed to eradicate VAP.
• There is a need for novel strategies to manage lower respiratory tract infections in ventilated patients.

Purpose of the Study:

• To explore the concept of VAT as an intermediate or less severe form of VAP.
• To highlight the importance of preventing VAT progression to VAP.

Main Methods:

• Conceptual review and synthesis of existing literature on ventilator-associated lower respiratory tract infections.
• Analysis of the relationship between VAT and VAP.

Main Results:

• VAT may represent a distinct clinical entity or a spectrum of VAP.
• Current VAP prevention strategies have proven insufficient.

Conclusions:

• Shifting focus to preventing VAT progression to VAP could significantly improve patient outcomes.
• New conceptual frameworks are urgently needed for managing ventilator-associated respiratory infections.